Author:
Berchem G. J.,Ries F.,Hanfelt J.,Duhem C.,Keipes M.,Delagardelle C.,Dicato M.
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Bonfante V, Villani F, Bonadonna G, et al (1982) Toxic and therapeutic activity of 4 epi-doxorubicin. Tumori 68:105?111
2. Brambilla C, Rossi A, Bonfante V, Ferrari L, Villani F, Crippa F, Bonadonna G (1986) Phase II study of doxorubicin versus epirubicin in advanced breast cancer. Cancer Treat Rep 70:261?266
3. Cerosimo RJ, Hong WK, et al (1986) Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue. J Clin Oncol Mar 4:425?439
4. Dardir MD, Ferrans VJ, Mikhael YS, et al (1989) Cardiac morphologic and functional changes induced by epirubicin chemotherapy. J Clin Oncol 7:947?958
5. French Epirubicin Study Group (1988) A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. J Clin Oncol 6:679?688
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献